Ventricular Assist Device and Intra-Aortic Balloon Pump Device Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: Percutaneous VAD Market, Implantable VAD Market, IABP Catheter Market and IABP Console Market

  • Year: 2024
  • Scope: 10 Years
  • Region: Global
  • Pages: 105
  • Published Date: 04/12/2024
  • Type: MedCore

Product Description

Overall, the global ventricular assist device market was valued at $2.2 billion in 2023. This is expected to increase over the forecast period at a CAGR of 2.9% to reach 2.8 billion. Overall, the global intra-aortic balloon device market was valued at $196 million in 2023. This is expected to increase over the forecast period at a CAGR of 2.8% to reach $237 million.

Abiomed, Abbott, and LivaNova were the share leaders in the global ventricular assist device (VAD) market. This global analysis covers over 70 countries, includes in-depth procedure numbers by country, and is segmented into the Percutaneous VAD Market and the Implantable VAD Market. The method for VAD replacement is highly invasive, usually requiring open-heart surgery via a median sternotomy. This will continue to play a limiting role in the widespread adoption and growth of the market.

Getinge and Teleflex were the share leaders in the global intra-aortic balloon pump catheter (IABP) market. This global analysis covers over 70 countries, and in-depth procedure numbers, and is segmented into the IABP Catheter Market and the IABP Console Market. A major limiter to growth in the IABP market is the competition with other product classes.

MARKET DATA INCLUDED

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2030, and Historical Data to 2020
  • Recent Mergers & Acquisitions
  • Disease Overviews
  • Company Profiles, Product Portfolios, and SWOT for Top Competitors

Ventricular Assist Device Market Insights

Global Ventricular Assist Device Market

Globally, the number of patients experiencing heart failure is rising, and all are potential candidates for Ventricular Assist Devices (VADs), whether implanted or percutaneous, through the forecast period. This increase in potential recipients is expected to propel market growth over the next seven years. With Medtronic exiting the market, a significant opportunity has arisen for remaining companies to invest in enhancing their VAD product lines as competition intensifies. This strategic shift is anticipated to reshape the competitive landscape.

Intra-Aortic Balloon Pump Catheter Market Insights

Global Intra-Aortic Balloon Device Market

Intra-aortic Balloon Pumps (IABPs) are frequently utilized during Percutaneous Coronary Interventions (PCIs). As the volume of PCIs increases, so too will the sales of IAB devices. This correlation is expected to stimulate market growth throughout the forecast period. Within the IAB catheter market, a notable trend is fostering segment growth: fiber-optic catheters are increasingly replacing conventional ones. This innovation enhances patient outcomes, leading to a rise in the procedures performed.

MARKET SHARE INSIGHTS

The global Intra-Aortic Balloon and Ventricular Assist markets are controlled by Abiomed, Abbott, LivaNova, Getinge, and Teleflex.Global Ventricular Assist Device Market and Global Intra-Aortic Balloon Pump Device Market

 

FREE Sample Report

Ventricular Assist Device Market
18.1 Executive Summary
18.1.1 Global Ventricular Assist Device Market Overview
18.1.2 Competitive Analysis
18.1.3 Procedures Included
18.1.4 Markets Included
18.1.5 Regions Included
18.2 Introduction
18.3 Procedure Numbers
18.3.1 Total Ventricular Assist Device Procedures
18.3.2 Percutaneous VAD Procedures
18.3.3 Implantable VAD Procedures
18.4 Market Overview
18.4.1 By Segment
18.4.2 By Region
18.5 Market Analysis and Forecast
18.5.1 Total Ventricular Assist Device Market
18.5.2 Implantable VAD Market
18.5.3 Percutaneous VAD Market
18.6 Drivers and Limiters
18.6.1 Market Drivers
18.6.2 Market Limiters
18.7 Competitive Market Share Analysis
Intra-Aortic Balloon Device Market
19.1 Executive Summary
19.1.1 Global Intra-Aortic Balloon Device Market Overview
19.1.2 Competitive Analysis
19.1.3 Procedures Included
19.1.4 Markets Included
19.1.5 Regions Included
19.2 Introduction
19.3 Procedure Numbers
19.4 Market Overview
19.4.1 By Segment
19.4.2 By Region
19.5 Market Analysis and Forecast
19.5.1 IAB Catheter Market
19.5.2 IABP Console Market
19.6 Drivers and Limiters
19.6.1 Market Drivers
19.6.2 Market Limiters
19.7 Competitive Market Share Analysis
Getinge
Teleflex
Abiomed
Abbott
LivaNova
Others
Chart 18‑1: Ventricular Assist Device Market, Global, 2023 & 2030
Chart 18‑2: Ventricular Assist Device Procedures, Global, 2023
Chart 18‑3: Ventricular Assist Device Procedures by Segment, Global, 2020 – 2030
Chart 18‑4: Ventricular Assist Device Market by Segment, Global, 2020 – 2030
Chart 18‑5: Ventricular Assist Device Market by Region, Global, 2020 – 2030
Chart 18‑6: Leading Competitors, Ventricular Assist Device Market, Global, 2023
Chart 19‑1: Intra-Aortic Balloon Device Market, Global, 2023 & 2030
Chart 19‑2: Intra-Aortic Balloon Device Procedures, Global, 2023
Chart 19‑3: Intra-Aortic Balloon Pump Procedures by Region, Global, 2020 – 2030
Chart 19‑4: Intra-Aortic Balloon Device Market by Segment, Global, 2020 – 2030
Chart 19‑5: Intra-Aortic Balloon Device Market by Region, Global, 2020 – 2030
Chart 19‑6: Leading Competitors, Intra-Aortic Balloon Device Market, Global, 2023
Figure 18‑1: Ventricular Assist Device Procedures Covered
Figure 18‑2: Ventricular Assist Device Markets Covered
Figure 18‑3: Ventricular Assist Device Regions Covered, Global (1 of 2)
Figure 18‑4: Ventricular Assist Device Regions Covered, Global (2 of 2)
Figure 18‑5: Total Ventricular Assist Device Procedures by Type, Global, 2020 – 2030
Figure 18‑6: Ventricular Assist Device Procedures by Region, Global, 2020 – 2030
Figure 18‑7: Ventricular Assist Device Procedures by Country, North America, 2020 – 2030
Figure 18‑8: Ventricular Assist Device Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 18‑9: Ventricular Assist Device Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 18‑10: Ventricular Assist Device Procedures by Country, Western Europe, 2020 – 2030
Figure 18‑11: Ventricular Assist Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 18‑12: Ventricular Assist Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 18‑13: Ventricular Assist Device Procedures by Country, Middle East, 2020 – 2030
Figure 18‑14: Ventricular Assist Device Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 18‑15: Ventricular Assist Device Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 18‑16: Ventricular Assist Device Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 18‑17: Ventricular Assist Device Procedures by Country, Africa, 2020 – 2030
Figure 18‑18: Percutaneous VAD Procedures by Region, Global, 2020 – 2030
Figure 18‑19: Percutaneous VAD Procedures by Country, North America, 2020 – 2030
Figure 18‑20: Percutaneous VAD Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 18‑21: Percutaneous VAD Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 18‑22: Percutaneous VAD Procedures by Country, Western Europe, 2020 – 2030
Figure 18‑23: Percutaneous VAD Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 18‑24: Percutaneous VAD Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 18‑25: Percutaneous VAD Procedures by Country, Middle East, 2020 – 2030
Figure 18‑26: Percutaneous VAD Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 18‑27: Percutaneous VAD Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 18‑28: Percutaneous VAD Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 18‑29: Percutaneous VAD Procedures by Country, Africa, 2020 – 2030
Figure 18‑30: Implantable VAD Procedures by Region, Global, 2020 – 2030
Figure 18‑31: Implantable VAD Procedures by Country, North America, 2020 – 2030
Figure 18‑32: Implantable VAD Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 18‑33: Implantable VAD Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 18‑34: Implantable VAD Procedures by Country, Western Europe, 2020 – 2030
Figure 18‑35: Implantable VAD Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 18‑36: Implantable VAD Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 18‑37: Implantable VAD Procedures by Country, Middle East, 2020 – 2030
Figure 18‑38: Implantable VAD Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 18‑39: Implantable VAD Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 18‑40: Implantable VAD Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 18‑41: Implantable VAD Procedures by Country, Africa, 2020 – 2030
Figure 18‑42: Ventricular Assist Device Market by Segment, Global, 2020 – 2030 (US$M)
Figure 18‑43: Ventricular Assist Device Market by Region, Global, 2020 – 2030 (US$M)
Figure 18‑44: Ventricular Assist Device Market, Global, 2020 – 2030
Figure 18‑45: Units Sold by Region, Ventricular Assist Device Market, Global, 2020 – 2030
Figure 18‑46: Average Selling Price by Region, Ventricular Assist Device Market, Global, 2020 – 2030 (US$)
Figure 18‑47: Market Value by Region, Ventricular Assist Device Market, Global, 2020 – 2030 (US$M)
Figure 18‑48: Implantable VAD Market, Global, 2020 – 2030
Figure 18‑49: Units Sold by Region, Implantable VAD Market, Global, 2020 – 2030
Figure 18‑50: Average Selling Price by Region, Implantable VAD Market, Global, 2020 – 2030 (US$)
Figure 18‑51: Market Value by Region, Implantable VAD Market, Global, 2020 – 2030 (US$M)
Figure 18‑52: Percutaneous VAD Market, Global, 2020 – 2030
Figure 18‑53: Units Sold by Region, Percutaneous VAD Market, Global, 2020 – 2030
Figure 18‑54: Average Selling Price by Region, Percutaneous VAD Market, Global, 2020 – 2030 (US$)
Figure 18‑55: Market Value by Region, Percutaneous VAD Market, Global, 2020 – 2030 (US$M)
Figure 18‑56: Leading Competitors, Ventricular Assist Device Market, Global, 2023
Figure 19‑1: Intra-Aortic Balloon Device Procedures Covered
Figure 19‑2: Ventricular Assist Device Markets Covered
Figure 19‑3: Intra-Aortic Balloon Device Regions Covered, Global (1 of 2)
Figure 19‑4: Intra-Aortic Balloon Device Regions Covered, Global (2 of 2)
Figure 19‑5: Intra-Aortic Balloon Pump Procedures by Region, Global, 2020 – 2030
Figure 19‑6: Intra-Aortic Balloon Pump Procedures by Country, North America, 2020 – 2030
Figure 19‑7: Intra-Aortic Balloon Pump Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 19‑8: Intra-Aortic Balloon Pump Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 19‑9: Intra-Aortic Balloon Pump Procedures by Country, Western Europe, 2020 – 2030
Figure 19‑10: Intra-Aortic Balloon Pump Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 19‑11: Intra-Aortic Balloon Pump Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 19‑12: Intra-Aortic Balloon Pump Procedures by Country, Middle East, 2020 – 2030
Figure 19‑13: Intra-Aortic Balloon Pump Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 19‑14: Intra-Aortic Balloon Pump Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 19‑15: Intra-Aortic Balloon Pump Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 19‑16: Intra-Aortic Balloon Pump Procedures by Country, Africa, 2020 – 2030
Figure 19‑17: Intra-Aortic Balloon Device Market by Segment, Global, 2020 – 2030 (US$M)
Figure 19‑18: Intra-Aortic Balloon Device Market by Region, Global, 2020 – 2030 (US$M)
Figure 19‑19: IAB Catheter Market, Global, 2020 – 2030
Figure 19‑20: Units Sold by Region, IAB Catheter Market, Global, 2020 – 2030
Figure 19‑21: Average Selling Price by Region, IAB Catheter Market, Global, 2020 – 2030 (US$)
Figure 19‑22: Market Value by Region, IAB Catheter Market, Global, 2020 – 2030 (US$M)
Figure 19‑23: IABP Console Market, Global, 2020 – 2030
Figure 19‑24: Units Sold by Region, IABP Console Market, Global, 2020 – 2030
Figure 19‑25: Average Selling Price by Region, IABP Console Market, Global, 2020 – 2030 (US$)
Figure 19‑26: Market Value by Region, IABP Console Market, Global, 2020 – 2030 (US$M)
Figure 19‑27: Installed Base by Region, IABP Console Market, Global, 2020 – 2030 (US$M)
Figure 19‑28: Leading Competitors, Intra-Aortic Balloon Device Market, Global, 2023

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

Ventricular assist devices (VADs) are used to aid a failing heart by supplementing the pumping function of the heart. VADs are often used in patients with advanced heart failure (HF). HF is a chronic disease that occurs when degeneration of the heart muscle reduces the pump power of the heart, which causes the heart to become too weak to pump blood at a level sufficient to meet the body’s demands.

  • 2024
  • 10 Years
  • Global
  • MedCore
  • 105
  • 04/12/2024
SKU: iDATA_GLCS24_MC_VAD Categories: , , , ,
Request Sample Sheets Request Customization
Related Reports
+

REQUEST SAMPLE SHEETS

+

REQUEST CUSTOMIZATION

+

Free Sample Report Form

+

See Report Summary

0
    0
    Your Cart
    Your cart is emptyReturn to Report Library